Kronos Bio, Inc. (KRON)
0.8800
0.00 (0.00%)
Inactive · Last trade price on Jun 20, 2025

Kronos Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
9.199.856.29---
Revenue Growth
21.15%56.62%----
Gross Profit
9.199.856.29---
Operating Income
-50.6-63.43-117.2-137.12-151.4-58.04
Net Income
-64.49-86.08-112.67-133.2-151.08-88.44
Earnings Per Share
-1.07-1.43-1.95-2.37-2.76-5.43
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
99.73112.42173238.19339.51413.06
Total Debt
24.0924.928.2731.0933.7632.06
Net Cash (Debt)
75.6587.52144.73207.09305.75381
Net Cash Growth
-39.25%-39.52%-30.12%-32.27%-19.75%315.71%
Net Cash Per Share
1.251.462.513.685.5823.41

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-54.38-65.44-78.58-90.93-117.92-37.91
Capital Expenditures
0-0-0.68-0.58-4.26-9.57
Free Cash Flow
-54.38-65.44-79.26-91.5-122.18-47.48
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-550.46%-644.11%-1863.88%---
Pretax Margin
-701.53%-874.08%-1791.87%---
Profit Margin
-701.53%-874.08%-1791.87%---
FCF Margin
-591.55%-664.49%-1260.51%---

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
5.785.8211.59---